VTYX Stock Quote Price and Forecast | CNN

VTYX

Ventyx Biosciences, Inc.

Key terms

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded on November 21, 2018 and is headquartered in San Diego, CA.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

May 16 8:22am ET Ventyx Biosciences Names Matthew Moore New COO by TipRanks May 16 8:08am ET Ventyx Biosciences announces appointment of Moore as COO by TipRanks May 15 10:05pm ET Stifel Nicolaus Keeps Their Hold Rating on Ventyx Biosciences (VTYX) by TipRanks May 13 7:00am ET Analysts Offer Insights on Healthcare Companies: Quantum-Si (QSI), Savara (SVRA) and Ventyx Biosciences (VTYX) by TipRanks May 10 8:05am ET Piper Sandler Reaffirms Their Buy Rating on Ventyx Biosciences (VTYX) by TipRanks May 10 7:58am ET Ventyx Biosciences (VTYX) Receives a Buy from Oppenheimer by TipRanks May 10 7:30am ET Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Incyte (INCY) and Ventyx Biosciences (VTYX) by TipRanks May 10 6:28am ET Ventyx Biosciences: A Prudent Hold Amidst Promising Drug Potential and Market Uncertainties by TipRanks May 10 5:59am ET Buy Rating for Ventyx Biosciences Based on Clinical and Financial Strengths by TipRanks May 09 4:09pm ET Ventyx Biosciences reports Q1 EPS (62c), consensus (67c) by TipRanks Apr 09 1:32am ET Class Action Lawsuit against Ventyx Biosciences, Inc. (NASDAQ:VTYX) by TipRanks Apr 05 5:22pm ET Ventyx Biosciences CBO Christopher Krueger Steps Down by TipRanks Apr 01 10:05am ET Ventyx Biosciences (VTYX) Gets a Buy from LifeSci Capital by TipRanks Mar 13 7:34am ET Ventyx Biosciences price target lowered to $15 from $16 at Canaccord by TipRanks Mar 13 7:06am ET Buy Rating Affirmed for Ventyx Biosciences on Strong Clinical Pipeline and Promising Drug Developments by TipRanks Mar 12 8:45am ET Largest borrow rate increases among liquid names by TipRanks Mar 12 7:16am ET Buy Rating Affirmed: Ventyx Biosciences’ Promising Clinical Advances and Strategic Position for Market Opportunities by TipRanks Mar 12 6:35am ET Ventyx Biosciences (VTYX) Receives a New Rating from Piper Sandler by TipRanks Mar 12 6:33am ET Wells Fargo more bullish on Ventyx Biosciences, upgrades to Overweight by TipRanks Mar 12 6:28am ET Hold Rating on Ventyx Biosciences Amid Pipeline Uncertainties and Strategic Partnerships Search by TipRanks Mar 12 5:12am ET Ventyx Biosciences upgraded to Overweight from Equal Weight at Wells Fargo by TipRanks Mar 12 4:43am ET Ventyx Biosciences upgraded to Outperform on new focus at Oppenheimer by TipRanks Mar 11 6:34pm ET Ventyx Biosciences upgraded to Outperform from Perform at Oppenheimer by TipRanks Mar 11 10:50am ET Ventyx Biosciences to hold virtual investor event by TipRanks Mar 11 9:48am ET Ventyx Biosciences trading resumes by TipRanks Mar 11 9:43am ET Ventyx Biosciences trading halted, volatility trading pause by TipRanks Mar 11 7:21am ET Ventyx Biosciences expects cash to fund operations into 2H26 by TipRanks Mar 11 7:21am ET Ventyx Biosciences provides NLRP3 Inhibitor data, pipelne updates by TipRanks Mar 11 6:49am ET Ventyx Biosciences price target lowered to $16 from $20 at Canaccord by TipRanks Mar 11 4:55am ET Ventyx Biosciences to hold virtual investor event by TipRanks Mar 09 4:20pm ET Ventyx Biosciences to hold virtual investor event by TipRanks

May 13 9:02pm ET VTYX ALERT: Top Law Firm Bleichmar Fonti & Auld LLP Is Investigating the Directors of Ventyx Biosciences, Inc. for Potential Breaches of Fiduciary Duty; Contact the Firm for More Details by Newsfile Apr 30 2:15pm ET April 30, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTYX by Accesswire Apr 30 12:45pm ET Class Action Filed Against Ventyx Biosciences, Inc. (VTYX) Seeking Recovery for Investors - Contact Levi & Korsinsky by Accesswire Apr 30 11:00am ET Shareholders that lost money on Ventyx Biosciences, Inc.(VTYX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More by Accesswire Apr 30 10:47am ET SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTYX by Newsfile Apr 30 10:13am ET FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ventyx Biosciences by Newsfile Apr 30 8:50am ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Biosciences, Inc. Lawsuit - VTYX by Accesswire Apr 30 8:00am ET FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm by Accesswire Apr 30 4:40am ET Levi & Korsinsky Notifies Shareholders of Ventyx Biosciences, Inc. (VTYX) of a Class Action Lawsuit and an Upcoming Deadline by Accesswire Apr 30 4:36am ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Lawsuit - VTYX by Accesswire Apr 29 2:30pm ET Levi & Korsinsky Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX by Accesswire Apr 29 10:20am ET TUESDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm by Newsfile Apr 29 10:04am ET UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ventyx Biosciences by Newsfile Apr 28 8:00pm ET Contact Levi & Korsinsky by April 30, 2024 Deadline to Join Class Action Against Ventyx Biosciences, Inc.(VTYX) by Accesswire Apr 28 7:45pm ET Contact Levi & Korsinsky by April 30, 2024 Deadline to Join Class Action Against Ventyx Biosciences, Inc.(VTYX) by Accesswire Apr 28 7:00pm ET FINAL DEADLINE TUESDAY: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm by Accesswire Apr 28 2:33pm ET VTYX LAWSUIT ALERT: Levi & Korsinsky Notifies Ventyx Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline by Accesswire Apr 28 1:00pm ET FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses of $100,000 to Contact the Firm by Accesswire Apr 28 10:29am ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Lawsuit - VTYX by Accesswire Apr 28 9:26am ET DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ventyx Biosciences by Newsfile Apr 28 8:33am ET Levi & Korsinsky Reminds Ventyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX by Accesswire Apr 28 7:31am ET Ventyx Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your Rights - VTYX by Accesswire Apr 28 7:29am ET Ventyx Biosciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your Rights - VTYX by Accesswire Apr 27 6:06pm ET VTYX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX by Newsfile Apr 27 9:04am ET ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ventyx Biosciences by Newsfile Apr 26 6:06pm ET VTYX DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX by Newsfile Apr 26 10:41am ET TUESDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm by Newsfile Apr 26 8:30am ET Investors in Ventyx Biosciences, Inc. Should Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your Rights - VTYX by Accesswire Apr 26 5:40am ET Levi & Korsinsky Notifies Ventyx Biosciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - VTYX by Accesswire Apr 26 5:40am ET Ventyx Biosciences, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your Rights - VTYX by Accesswire Apr 25 6:05pm ET VTYX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX by Newsfile

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Dave Calhoun, chief executive officer of Boeing Co., center right, on Capitol Hill in Washington, DC, US, on Wednesday, Jan. 24, 2024. The company is working to assure airline customers and the Federal Aviation Administration that its jets are safe after a January 5 accident, which involved a faulty door panel on a 737 Max 9 aircraft operated by Alaska Airlines.

Samuel Corum/Bloomberg/Getty Images

Boeing shareholders vote to approve $33 million CEO pay package

ZHANGYE, CHINA - APRIL 16, 2024 - Workers check photovoltaic panels before packing at the New Material 800MW high-efficiency photovoltaic module production line in Zhangye city, Gansu province, China, April 16, 2024.

CFOTO/Future Publishing/Getty Images

Biden’s tariffs on Chinese imports are boosting these beaten-down stocks

Traders work on the floor of the New York Stock Exchange on May 16, 2024. Wall Street is buoyed by hopes the Federal Reserve will pull back on its restrictive monetary policy after data showed inflation is beginning to ease.

Spencer Platt/Getty Images

Dow briefly tops 40,000 for first time but ends the day lower

Shoppers at a Walmart store in Secaucus, New Jersey, US, on Tuesday, March 5, 2024. Walmart is revamping more than 800 store locations and adding high-end products.

Gabby Jones/Bloomberg/Getty Images

Walmart’s business surges as shoppers hunt for low prices